Latest from the Blog

1. October 8, 2019

   NBTS Brain Tumor Clinical Trials Report – October 2019

   

   Brain tumor clinical trials open around the country all the time, and it can be hard for patients and care partners to keep track of new opportunities to consider participation in leading-edge clinical research. This report, generated by the National Brain Tumor Society, provides a summary of clinical trials that have started or begun recruitment […]

   Read more | 

   Tags: astrocytoma, brain cancer, brain tumor, Cancer, chemotherapy, childhood cancer, Clinical trials, DIPG, Ependymoma, GBM, glioblastoma, glioma, high-grade glioma, immunotherapy, low-grade glioma, Medulloblastoma, NCI, neurosurgery, NIH, pediatric brain tumor, pediatric cancer, precision medicine, Treatment
2. October 7, 2019

   Top Five Blogs: July – September 2019

   

   Below is a recap of the most popular brain tumor news and blog items from Q3 2019 (July – Sept.) on the NBTS site, as measured by YOUR readership and views. We hope you’ll enjoy catching up on anything you may have missed! 1. A Missing Link to Glioblastoma Growth? Research funded through NBTS’s Defeat […]

   Read more | 

   Tags: advocacy, brain cancer, brain tumor, brain tumor community, Cancer, childhood cancer, Community, Defeat GBM, GBM, glioblastoma, Patient life, pediatric, pediatric brain tumor, pediatric cancer, pediatrics, precision medicine, Treatment
3. September 30, 2019

   September Superstars Shine Bright During Childhood Cancer Awareness Month

   

   Thank you for joining us throughout the month of September to honor and support children and families that have been affected by pediatric brain tumors, the leading cause of cancer-related death in children, as well as the most commonly diagnosed cancer in children 14 years old and younger. It’s clear the brain tumor community has […]

   Read more | 

   Tags: advocacy, brain cancer, brain tumor, brain tumor community, Cancer, childhood cancer, Community, pediatric cancer, pediatrics